Libraf SA
0.9 FTEThe score of Libraf shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity 0 % Total assets -35 % Headcount (avg FTE) 0 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Libraf's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 70,494 € | ||||
| Equity | 152,528 € | ||||
| Cash | 113,935 € | ||||
| EBITDA | 162,558 € | ||||
| Total assets | 616,697 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 02 Jul 2026
- Year ended 31 Dec 2024filed on 10 Jun 2025
- Year ended 31 Dec 2023filed on 12 Jul 2024
- Year ended 31 Dec 2022filed on 16 Aug 2023
- Year ended 31 Dec 2021filed on 25 Aug 2022
Libraf's financial analysis
- Solvency24.7%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Libraf
Libraf's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0429.367.827
- VAT number
- BE0429367827
- Peppol
- Registered · 0208:0429367827 · as of 27 Oct 2026
- Legal form
- SA
- Incorporated
- 19 Aug 1986
- Registered office
- 1600 Sint-Pieters-Leeuw
- Size
- Micro · 0.9 FTE
- Latest accounts
- 2025 · filed on 02 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Libraf (SA) has been based in Sint-Pieters-Leeuw since 1986, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 70,494 € and equity of 152,528 €; its revenue is not published. With 0.9 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 24.7%, below the median of its sector (44.2%).
Companies similar to Libraf
Companies in the same business, of comparable size and area, outside its group.
- Apotheek Theunis Retail sale of pharmaceutical products Hasselt · balance sheet 616,611 €
- Pharmacie Spelmans Retail sale of pharmaceutical products Liège · balance sheet 617,149 €
- Poppe Apotheek Retail sale of pharmaceutical products Aalst · balance sheet 616,163 €
- Senne Pharma Retail sale of pharmaceutical products Soignies · balance sheet 617,578 €
- PH DE Linde Retail sale of pharmaceutical products Anderlecht · balance sheet 619,651 €
- DE Zeven Hoeken Retail sale of pharmaceutical products Anderlecht · balance sheet 613,685 €
- Pharmadil Retail sale of pharmaceutical products Dilbeek · balance sheet 620,651 €
- Heldo Retail sale of pharmaceutical products Erpe-Mere · balance sheet 621,357 €
Frequently asked questions about Libraf
What is the revenue of Libraf?
Libraf files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Libraf?
In Belgium, the VAT number is the company number prefixed with BE: BE0429367827 for Libraf, if the company is VAT-registered. Its company number (CBE) is 0429.367.827.
Where is the registered office of Libraf?
According to the CBE register, the registered office of Libraf is in 1600 Sint-Pieters-Leeuw.
What is the equity of Libraf?
At the close of the 2025 financial year, the equity of Libraf amounts to 152,528 €, a solvency of 24.7% of total assets.
How many people work at Libraf?
0.9 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Libraf?
The register lists 3 active mandates at Libraf. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Libraf
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →